First, TQ may have enhanced the sensitivity of the pancreatic cancer cells to GEM by inhibiting the neurogenic gene Notch homolog protein 1/phosphorase and tensin homolog (Notch1/PTEN) pathway. The gene discussed is NOTCH1; the disease is familial pancreatic carcinoma.